Focused Wealth Management’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,520
| Closed | -$9K | – | 852 |
|
|
2019
Q1 | $9K | Sell |
1,520
-775
| -34% | -$2.64K | ﹤0.01% | 484 |
|
|
2018
Q4 | $3K | Buy |
2,295
+480
| +26% | +$834 | ﹤0.01% | 610 |
|
|
2018
Q3 | $6K | Sell |
1,815
-4,580
| -72% | -$17.2K | ﹤0.01% | 514 |
|
|
2018
Q2 | $29K | Sell |
6,395
-6,000
| -48% | -$23.9K | 0.01% | 327 |
|
|
2018
Q1 | $41K | Buy |
12,395
+10,000
| +418% | +$35.4K | 0.01% | 314 |
|
|
2017
Q4 | $9K | Sell |
2,395
-10,670
| -82% | -$58.1K | ﹤0.01% | 490 |
|
|
2017
Q3 | $135K | Buy |
13,065
+1,070
| +9% | +$10.5K | 0.05% | 142 |
|
|
2017
Q2 | $117K | Hold |
11,995
| – | – | 0.04% | 204 |
|
|
2017
Q1 | $82K | Buy |
11,995
+330
| +3% | +$1.91K | 0.03% | 234 |
|
|
2016
Q4 | $64K | Sell |
11,665
-7,303
| -39% | -$51.6K | 0.03% | 248 |
|
|
2016
Q3 | $144K | Buy |
18,968
+3,100
| +20% | +$22.7K | 0.06% | 184 |
|
|
2016
Q2 | $129K | Sell |
15,868
-725
| -4% | -$9.04K | 0.06% | 188 |
|
|
2016
Q1 | $216K | Buy |
16,593
+3,695
| +29% | +$42.7K | 0.12% | 102 |
|
|
2015
Q4 | $259K | Buy |
12,898
+2,252
| +21% | +$38.8K | 0.15% | 96 |
|
|
2015
Q3 | $130K | Buy |
10,646
+7,240
| +213% | +$136K | 0.08% | 124 |
|
|
2015
Q2 | $70K | Sell |
3,406
-503
| -13% | -$11.9K | 0.04% | 171 |
|
|
2015
Q1 | $83K | Buy |
3,909
+2,275
| +139% | +$59.4K | 0.05% | 154 |
|
|
2014
Q4 | $50K | Buy |
1,634
+1,184
| +263% | +$32.9K | 0.04% | 191 |
|
|
2014
Q3 | $8K | Buy |
+450
| New | +$5.69K | 0.01% | 466 |
|
Focused Wealth Management's IMDZ Position: Q2 2019 in Review
Focused Wealth Management sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 1,520 shares — an estimated $9K sold.
Focused Wealth Management first reported a position in IMDZ in Q3 2014 and held it in 19 quarters. The position peaked at $259K in Q4 2015. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- Focused Wealth Management reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- Focused Wealth Management sold 1,520 Immune Design Corp. shares in Q2 2019, an estimated $9K.
- Focused Wealth Management first reported a position in Immune Design Corp. in Q3 2014 and held it in 19 quarters.
- Focused Wealth Management's Immune Design Corp. position peaked at $259K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on Focused Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.